0.05Open0.09Pre Close2 Volume2.09K Open Interest86.00Strike Price10.00Turnover59.36%IV12.62%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0285Delta0.0140Gamma1528.20Leverage Ratio-0.0320Theta0.0002Rho43.59Eff Leverage0.0051Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet